COVID-19 Resources for Blood Donor Centers
Developed with input from federal regulators, AABB’s regulatory resources are clear, user-friendly tools that help blood centers and transfusion services protect donor and patient safety at each step in the transfusion chain.
Reporting Fatalities Related to Blood Transfusion and Donation to FDA
REGULATORY UPDATE: AABB Introduces New FDA Blood Establishment Registration Toolkit
September 19, 2025
FDA to Host Virtual Town Hall on Gene Therapy Manufacturing
September 11, 2025
REGULATORY UPDATE: FDA Withdraws EUA for COVID-19 Convalescent Plasma
September 10, 2025